Alon Bloomenfeld
Vorstandsvorsitzender bei Raziel Therapeutics RT Ltd.
Profil
Alon Bloomenfeld is currently the Chief Executive Officer and Director at Raziel Therapeutics RT Ltd.
He previously held positions as Chairman at Eqlibra Medical Systems Ltd., Director at ElectReon Wireless Ltd., Director at Meytav Technological Enterprises Innovation Center Ltd., and Director at Orbix Medical Ltd.
Aktive Positionen von Alon Bloomenfeld
| Unternehmen | Position | Beginn |
|---|---|---|
Raziel Therapeutics RT Ltd.
 Raziel Therapeutics RT Ltd. Pharmaceuticals: MajorHealth Technology Raziel Therapeutics RT Ltd. develops innovative technology to treat obesity disease. It is developing RZL-12, is a potential first-in-class, injectable drug for the reduction of fat cell mass. the firm developed a novel drug (NCE) that after a single injection into subcutaneous fat, converts white adipose tissue (WAT) into brown adipose tissue-like. The company was founded by Shmuel A. Ben-Sasson in 2012 and is headquartered in Jerusalem, Israel. | Vorstandsvorsitzender | 08.08.2012 |
Ehemalige bekannte Positionen von Alon Bloomenfeld
| Unternehmen | Position | Ende |
|---|---|---|
Eqlibra Medical Systems Ltd.
 Eqlibra Medical Systems Ltd. Medical SpecialtiesHealth Technology Eqlibra Medical Systems Ltd. develops miniature intravascular flow augmentation devices. It offers tiny retrievable pump, intended to improve blood flow in the coronary arteries after an angioplasty catheterization. Its customers include medical institutions and hospitals. The company was founded on September 01, 2007 and is headquartered in Kiryat Shmona, Israel. | Vorsitzender | - |
| ELECTREON WIRELESS LTD | Direktor/Vorstandsmitglied | - |
Meytav Technological Enterprises Innovation Center Ltd.
 Meytav Technological Enterprises Innovation Center Ltd. Investment ManagersFinance Meytav Technological Enterprises Innovation Center Ltd is an Independent Venture Capital firm founded in 1991. The firm is headquartered in Kiryat Shmona. | Mitglied des Investmentausschusses | - |
Orbix Medical Ltd.
 Orbix Medical Ltd. Electronic Equipment/InstrumentsElectronic Technology Orbix Medical Ltd. manufactures and distributes medical equipment. It offers Orbishape and Orbisymm. The company was founded by Eyal Gur in 2004 and is headquartered in Tel Aviv, Israel. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ELECTREON WIRELESS LTD | Producer Manufacturing |
| Private Unternehmen | 4 |
|---|---|
Meytav Technological Enterprises Innovation Center Ltd.
Meytav Technological Enterprises Innovation Center Ltd. Investment ManagersFinance Meytav Technological Enterprises Innovation Center Ltd is an Independent Venture Capital firm founded in 1991. The firm is headquartered in Kiryat Shmona. | Finance |
Orbix Medical Ltd.
Orbix Medical Ltd. Electronic Equipment/InstrumentsElectronic Technology Orbix Medical Ltd. manufactures and distributes medical equipment. It offers Orbishape and Orbisymm. The company was founded by Eyal Gur in 2004 and is headquartered in Tel Aviv, Israel. | Electronic Technology |
Eqlibra Medical Systems Ltd.
Eqlibra Medical Systems Ltd. Medical SpecialtiesHealth Technology Eqlibra Medical Systems Ltd. develops miniature intravascular flow augmentation devices. It offers tiny retrievable pump, intended to improve blood flow in the coronary arteries after an angioplasty catheterization. Its customers include medical institutions and hospitals. The company was founded on September 01, 2007 and is headquartered in Kiryat Shmona, Israel. | Health Technology |
Raziel Therapeutics RT Ltd.
Raziel Therapeutics RT Ltd. Pharmaceuticals: MajorHealth Technology Raziel Therapeutics RT Ltd. develops innovative technology to treat obesity disease. It is developing RZL-12, is a potential first-in-class, injectable drug for the reduction of fat cell mass. the firm developed a novel drug (NCE) that after a single injection into subcutaneous fat, converts white adipose tissue (WAT) into brown adipose tissue-like. The company was founded by Shmuel A. Ben-Sasson in 2012 and is headquartered in Jerusalem, Israel. | Health Technology |
